TITLE

A novel mutation of the myelin P0 gene segregating Charcot-Marie-Tooth disease type 1B manifesting as trigeminal nerve thickening

AUTHOR(S)
SHIZUKA, MASAMI; IKEDA, YOSHIO; WATANABE, MITSUNORI; OKAMOTO, KOICHI; SHOJI, MIKIO; IKEGAMI, TORU; HAYASAKA, KIYOSHI
PUB. DATE
August 1999
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Aug1999, p250
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66877551

 

Related Articles

  • Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene. Taioli, Federica; Cabrini, Ilaria; Cavallaro, Tiziana; Acler, Michele; Fabrizi, Gian Maria // Brain: A Journal of Neurology;Feb2011, Vol. 134 Issue 2, p608 

    The peripheral myelin protein 22 gene (PMP22) encodes an intrinsic membrane protein of compact myelin. Duplication or deletion of PMP22 causes the most common autosomal dominant neuropathies, Charcot-Marie-Tooth disease type 1A or hereditary neuropathy with liability to pressure palsies....

  • Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease. Sevilla, Teresa; Lupo, Vincenzo; Martínez-Rubio, Dolores; Sancho, Paula; Sivera, Rafael; Chumillas, María J.; García-Romero, Mar; Pascual-Pascual, Samuel I.; Muelas, Nuria; Dopazo, Joaquín; Vílchez, Juan J.; Palau, Francesc; Espinós, Carmen // Brain: A Journal of Neurology;Jan2016, Vol. 139 Issue 1, p62 

    Charcot-Marie-Tooth disease (CMT) is a complex disorder with wide genetic heterogeneity. Here we present a new axonal Charcot-Marie-Tooth disease form, associated with the gene microrchidia family CW-type zinc finger 2 (MORC2). Whole-exome sequencing in a family with autosomal dominant...

  • Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy. Claeys, Kristl G.; Züchner, Stephan; Kennerson, Marina; Berciano, José; Garcia, Antonio; Verhoeven, Kristien; Storey, Elsdon; Merory, John R.; Bienfait, Henriette M. E.; Lammens, Martin; Nelis, Eva; Baets, Jonathan; De Vriendt, Els; Berneman, Zwi N.; De Veuster, Ilse; Vance, Jefferey M.; Nicholson, Garth; Timmerman, Vincent; De Jonghe, Peter // Brain: A Journal of Neurology;Jul2009, Vol. 132 Issue 7, p1741 

    Dominant intermediate Charcot-Marie-Tooth neuropathy type B is caused by mutations in dynamin 2. We studied the clinical, haematological, electrophysiological and sural nerve biopsy findings in 34 patients belonging to six unrelated dominant intermediate Charcot-Marie-Tooth neuropathy type B...

  • ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease. Montecchiani, Celeste; Pedace, Lucia; Lo Giudice, Temistocle; Casella, Antonella; Mearini, Marzia; Gaudiello, Fabrizio; Pedroso, José L.; Terracciano, Chiara; Caltagirone, Carlo; Massa, Roberto; George-Hyslop, Peter H. St; Barsottini, Orlando G. P.; Kawarai, Toshitaka; Orlacchio, Antonio; St George-Hyslop, Peter H // Brain: A Journal of Neurology;Jan2016, Vol. 139 Issue 1, p73 

    Charcot-Marie-Tooth disease is a group of hereditary peripheral neuropathies that share clinical characteristics of progressive distal muscle weakness and atrophy, foot deformities, distal sensory loss, as well as diminished tendon reflexes. Hundreds of causative DNA changes have been found, but...

  • Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene. Sanmaneechai, Oranee; Feely, Shawna; Scherer, Steven S.; Herrmann, David N.; Burns, Joshua; Muntoni, Francesco; Jun Li; Siskind, Carly E.; Day, John W.; Laura, Matilde; Sumner, Charlotte J.; Lloyd, Thomas E.; Ramchandren, Sindhu; Shy, Rosemary R.; Grider, Tiffany; Bacon, Chelsea; Finkel, Richard S.; Yum, Sabrina W.; Moroni, Isabella; Piscosquito, Giuseppe // Brain: A Journal of Neurology;Nov2015, Vol. 138 Issue 11, p3180 

    We aimed to characterize genotype-phenotype correlations and establish baseline clinical data for peripheral neuropathies caused by mutations in the myelin protein zero (MPZ) gene. MPZ mutations are the second leading cause of Charcot-Marie-Tooth disease type 1. Recent research makes clinical...

  • Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice. Klein, Dennis; Patzkó, Ágnes; Schreiber, David; van Hauwermeiren, Anemoon; Baier, Michaela; Groh, Janos; West, Brian L.; Martini, Rudolf // Brain: A Journal of Neurology;Nov2015, Vol. 138 Issue 11, p3193 

    See Scherer (doi:10.1093/awv279) for a scientific commentary on this article.Charcot-Marie-Tooth type 1 neuropathies are inherited disorders of the peripheral nervous system caused by mutations in Schwann cell-related genes. Typically, no causative cure is presently available. Previous...

  • Shortened internodal length of dermal myelinated nerve fibres in Charcot–Marie-Tooth disease type 1A. Saporta, Mario A.; Katona, Istvan; Lewis, Richard A.; Masse, Stacey; Shy, Michael E.; Li, Jun // Brain: A Journal of Neurology;Dec2009, Vol. 132 Issue 12, p3263 

    Charcot–Marie-Tooth disease type 1A is the most common inherited neuropathy and is caused by duplication of chromosome 17p11.2 containing the peripheral myelin protein-22 gene. This disease is characterized by uniform slowing of conduction velocities and secondary axonal loss, which are...

  • A novel mutation in VCP causes Charcot-Marie-Tooth Type 2 disease. Gonzalez, Michael A; Feely, Shawna M; Speziani, Fiorella; Strickland, Alleene V; Danzi, Matt; Bacon, Chelsea; Lee, Youjin; Chou, Tsui-Fen; Blanton, Susan H; Weihl, Conrad C; Zuchner, Stephan; Shy, Michael E // Brain: A Journal of Neurology;2014 Nov, Vol. 137 Issue Pt 11, p2897 

    Mutations in VCP have been reported to account for a spectrum of phenotypes that include inclusion body myopathy with Paget's disease of the bone and frontotemporal dementia, hereditary spastic paraplegia, and 1-2% of familial amyotrophic lateral sclerosis. We identified a novel VCP mutation...

  • Dynamin 2 mutations in Charcot–Marie–Tooth neuropathy highlight the importance of clathrin-mediated endocytosis in myelination. Sidiropoulos, Páris N. M.; Miehe, Michaela; Bock, Thomas; Tinelli, Elisa; Oertli, Carole I.; Kuner, Rohini; Meijer, Dies; Wollscheid, Bernd; Niemann, Axel; Suter, Ueli // Brain: A Journal of Neurology;May2012, Vol. 135 Issue 5, p1395 

    Mutations in dynamin 2 (DNM2) lead to dominant intermediate Charcot–Marie–Tooth neuropathy type B, while a different set of DNM2 mutations cause autosomal dominant centronuclear myopathy. In this study, we aimed to elucidate the disease mechanisms in dominant intermediate...

  • Distinctive genetic and clinical features of CMT4J: a severe neuropathy caused by mutations in the PI(3,5)P2 phosphatase FIG4. Nicholson, Garth; Lenk, Guy M.; Reddel, Stephen W.; Grant, Adrienne E.; Towne, Charles F.; Ferguson, Cole J.; Simpson, Ericka; Scheuerle, Angela; Yasick, Michelle; Hoffman, Stuart; Blouin, Randall; Brandt, Carla; Coppola, Giovanni; Biesecker, Leslie G.; Batish, Sat D.; Meisler, Miriam H. // Brain: A Journal of Neurology;Jul2011, Vol. 134 Issue 7, p1959 

    Charcot–Marie–Tooth disease is a genetically heterogeneous group of motor and sensory neuropathies associated with mutations in more than 30 genes. Charcot–Marie–Tooth disease type 4J (OMIM 611228) is a recessive, potentially severe form of the disease caused by...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics